Cargando…
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
The incidence of metastatic pheochromocytoma (PHEO) and paraganglioma (PGL) may occur in as many as 35% of patients particularly with PGL and even more frequently in those with specific mutations. Biochemical, morphological, and molecular markers have been investigated for use in the distinction of...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456409/ https://www.ncbi.nlm.nih.gov/pubmed/32862332 http://dx.doi.org/10.1007/s11864-020-00787-z |